MP61 - MP61: Bladder Cancer: Invasive III

Poster Presenter(s)

• 

  Ahmed Abdelgawad, MSC

  Clinical pharmacist and researcher at urology and nephrology center

  PDF Poster Slides and Audio
• 

  Alejandro Abello, MD

  Yale School of Medicine

  PDF Poster Slides
• 

  Muhannad Alsyouf, MD

  Loma Linda University

  PDF Poster Slides
• 

  Soroush Bazargani, MD

  University of Florida, Jacksonville College of Medicine, Department of Urology

  PDF Poster Slides and Audio
• 

  Giovanni Cacciamani, MD

  USC urology
• AC

  Alexander Chartier, BS

  Medical College of Wisconsin

  Poster
• 

  Kassem Faraj, MD

  Mayo Clinic Arizona

  PDF Poster Slides and Audio
• CH

  Chun Huang
• PK

  Pramit Khetrapal, MBBS

  University College London

  Poster
• 

  Qiang Lu

  The first affiliated hospital of Nanjing Medical University
• 

  Timothy Lyon, MD

  Mayo Clinic
• AM

  Amr Mahran MD MS
• 

  Gautier Marcq, MD,MSc, PhD Candidate

  McGill University

  Poster
• 

  Elio Mazzone, PHD

  San Raffaele Hospital
• MP

  Minuk Park
• FR

  Florian Roghmann
• 

  Vivek Venkatramani, MD

  Clinical Instructor
  University of Miami

  PDF Poster Slides and Audio
• WX

  Willem Xu, BA

  USC Keck
• LZ

  Logan Zemp

Presentations:

• 7:00 AM – 9:00 AM

  MP61-01: Comparative Analysis of the Extent of Lymph Node Dissection in Commonly Diagnosed Genitourinary and other Solid-organ Malignancies: A Systematic Review of Randomized Controlled Trials
  Soroush Bazargani, MD – University of Florida; Jacksonville
• 7:00 AM – 9:00 AM

  MP61-02: DETAILED CADAVERIC ANALYSIS FOR PERIVESICAL LYMPH NODES WITH POTENTIAL IMPLICATIONS IN BLADDER CANCER
  Muhannad Alsyouf, MD
• 7:00 AM – 9:00 AM

  MP61-03: Lymph node yield variability after radical cystectomy: the effect of pathological processing and microscopic examination
  Kassem Faraj, MD
• 7:00 AM – 9:00 AM

  MP61-04: Characterization and Distribution of Soft Tissue and Lymph Node Recurrences after Radical Cystectomy
  Chun Huang
• 7:00 AM – 9:00 AM

  MP61-05: FLUORESCENCE-GUIDED ROBOT ASSISTED URETERO-ILEAL REIMPLANTATION IN PATIENTS WITH BENIGN STRICTURE FOLLOWING INTRACORPOREAL URINARY DIVERSION
  Giovanni E. Cacciamani, MD
• 7:00 AM – 9:00 AM

  MP61-06: The role of wearable devices and CPET in predicting major complications after radical cystectomy
  Pramit Khetrapal, MBBS – UCL
• 7:00 AM – 9:00 AM

  MP61-07: A High 12-Chemokine Score is a Favorable Prognostic Indicator and Surrogate Marker for the Presence of Tertiary Lymphoid Structures in Bladder Cancer
  Logan Zemp
• 7:00 AM – 9:00 AM

  MP61-08: A Phase I/II Trial of Transurethral Surgery Followed by a Combination of Atezolizumab an Anti-PDL-1 (MPDL3280A) with Trimodal Therapy in Patients with Muscle-Invasive Bladder Cancer
  Gautier Marcq, MD,MSc, PhD Candidate
• 7:00 AM – 9:00 AM

  MP61-09: Predictors of postoperative complications after robotic and open radical cystectomy: An analysis from the RAZOR trial
  Vivek Venkatramani, MD – University of Miami - Miller School of Medicine
• 7:00 AM – 9:00 AM

  MP61-10: Prognostic role of FGFR alterations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first an second line setting
  Florian Roghmann
• 7:00 AM – 9:00 AM

  MP61-11: ROBOT-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL URINARY DIVERSION DECREASES POST-OPERATIVE COMPLICATIONS ONLY IN HIGHLY COMORBID PATIENTS
  Elio Mazzone, PHD – San Raffaele Hospital
• 7:00 AM – 9:00 AM

  MP61-12: National Variation in Lymph Node Dissection and Pathological Yield at the Time of Radical Cystectomy
  Alejandro Abello, MD
• 7:00 AM – 9:00 AM

  MP61-13: Do urinary-based molecular Biomarker have the ability to predict the grade of non-muscle invasive bladder cancer grade?
  Ahmed Mohamed Abdelgawad, MSC – Center of Excellence For Genome and Caner Res
• 7:00 AM – 9:00 AM

  MP61-14: Readmission rates and their predictors after robotic and open radical cystectomy: An analysis from the RAZOR trial
  Vivek Venkatramani, MD – University of Miami - Miller School of Medicine
• 7:00 AM – 9:00 AM

  MP61-15: Neoadjuvant Chemotherapy In Clinically Node Positive Urothelial Bladder Cancer
  Willem Xu, BA – USC
• 7:00 AM – 9:00 AM

  MP61-16: National Trends in Bladder Cancer: Sources of Potential Cost Variation in Cystectomy Care
  Amr Mahran MD MS
• 7:00 AM – 9:00 AM

  MP61-17: Molecular subtye transition, stromal infiltration and CD8 T-cell inflamed microenvironment in cystoscopy biopsy specimen improved predictive power of sensitivity to GC regiment NAC in MIBC
  Qiang Lu
• 7:00 AM – 9:00 AM

  MP61-18: A Nationwide Analysis of Complete Urinary Tract Extirpation
  Alexander Chartier, BS
• 7:00 AM – 9:00 AM

  MP61-19: Effect of Preoperative Renal Function on Prognosis in Muscle Invasive Bladder Cancer
  Minuk Park
• 7:00 AM – 9:00 AM

  MP61-20: Association of Intraoperative Hypothermia with Oncologic Outcomes Following Radical Cystectomy
  Timothy D. Lyon, MD